Company: NOEMW
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001013762-25-004368
Chunk: 309

Company: CO2 Energy Transition Corp.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1A
Chunk 309
---
 22, 2026)(or up to 24 months from the closing of our IPO
(November 22, 2026) if we extend the period of time to consummate a business combination, as described in more detail in this Report)
or (B) with respect to any other provision relating to stockholders’ rights or pre- initial business combination activity;
and (iii) their rights to liquidating distributions from the trust account with respect to any founder shares they hold if we fail
to complete our initial business combination within 18 months from the closing of the IPO (May 22, 2026)(or up to 24 months from the closing
of our IPO (November 22, 2026) if we extend the period of time to consummate a business combination, as described in more detail in this
Report) or during any Extension Period (although they will be entitled to liquidating distributions from the trust account with respect
to any public shares they hold if we fail to complete our initial business combination within the prescribed time frame); and (3) the
founder shares are entitled to registration rights. If we submit our initial business combination to our public stockholders for
a vote, our initial stockholders have agreed (and their respective permitted transferees will agree), pursuant to the terms of a letter
agreement entered into with us, to vote their founder shares and any public shares held by them purchased during or after our IPO in favor
of our initial business combination. While we do not expect our board of directors to approve any amendment to or waiver of the letter
agreement, investment agreements or registration rights agreement prior to our initial business combination, it may be possible that our
board of directors, in exercising its business judgment and subject to its fiduciary duties, chooses to approve one or more amendments
to or waivers of such agreements in connection with the consummation of our initial business combination. Any such amendments or waivers
would not require approval from our stockholders, may result in the completion of our initial business combination that may not otherwise
have been possible, and may have an adverse effect on the value of an investment in our securities.

The personal and financial
interests of our sponsor, directors and officers may influence their motivation in identifying and selecting a target business combination,
completing an initial business combination and influencing the operation of the business following the initial business combination. This
risk may become more acute as the 18-month deadline following